Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.

Spoorthy KulkarniMarie FiskMichalis KostapanosEdward Banham-HallSimon BondElena Hernan-SanchoSam NortonJoseph CheriyanAndrew CopeJames GallowayFrances HallDavid JayneIan B Wilkinson

Published in: Trials (2020)

Registered on EU Clinical Trials Register EudraCT Number: 2020-001354-22 Registered: 6 May 2020 It was registered on ClinicalTrials.gov ( NCT04390464 ) and on ISRCTN (ISRCTN11188345) FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.

Keyphrases

coronavirus disease
sars cov
randomized controlled trial
clinical trial
intensive care unit
end stage renal disease
newly diagnosed
ejection fraction
mechanical ventilation
prognostic factors
patient reported outcomes
study protocol
extracorporeal membrane oxygenation